Bayer’s BAY2927088 to face competition in EGFR-mutant but limited competition in HER2-exon 20 mutant NSCLC market in China: GlobalData Read more
Vertex could solidify dominance in cystic fibrosis market with vanza triple approval: GlobalData Read more
Moderna’s Covid-19/influenza vaccine phase III data highlights potential of mRNA technology for infectious diseases: GlobalData Read more
Amylyx’s efforts to explore other indications for Relyvrio seems to be bearing fruit: GlobalData Read more